M.-C. Villy, J. Masliah-Planchon, S. Melaabi, O. Trabelsi Grati, E. Girard, G. Bataillon, . . . C. Colas. (2021). Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants. Elsevier.
Chicago Style (17th ed.) CitationM.-C. Villy, et al. Tumor BRCA Testing Can Reveal a High Tumor Mutational Burden Related to POLE Pathogenic Variants. Elsevier, 2021.
MLA (9th ed.) CitationM.-C. Villy, et al. Tumor BRCA Testing Can Reveal a High Tumor Mutational Burden Related to POLE Pathogenic Variants. Elsevier, 2021.
Warning: These citations may not always be 100% accurate.